Thomas Stephan
Stock Analyst at Stifel
(1.48)
# 3,450
Out of 4,975 analysts
46
Total ratings
37.93%
Success rate
-7.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Initiates: Hold | $115 | $104.01 | +10.57% | 1 | Sep 4, 2025 | |
| STAA STAAR Surgical Company | Downgrades: Hold | $20 → $28 | $27.94 | +0.21% | 10 | Aug 7, 2025 | |
| GKOS Glaukos | Maintains: Buy | $140 → $115 | $93.94 | +22.42% | 9 | May 1, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $8.89 | +214.96% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $3.71 | +7.82% | 7 | Mar 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $15.01 | +19.92% | 3 | Jan 29, 2025 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.40 | +42.86% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $80.17 | +24.73% | 4 | May 15, 2024 |
TransMedics Group
Sep 4, 2025
Initiates: Hold
Price Target: $115
Current: $104.01
Upside: +10.57%
STAAR Surgical Company
Aug 7, 2025
Downgrades: Hold
Price Target: $20 → $28
Current: $27.94
Upside: +0.21%
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $93.94
Upside: +22.42%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $8.89
Upside: +214.96%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.71
Upside: +7.82%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $15.01
Upside: +19.92%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.40
Upside: +42.86%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $80.17
Upside: +24.73%